0001415889-22-002439.txt : 20220303
0001415889-22-002439.hdr.sgml : 20220303
20220303200626
ACCESSION NUMBER: 0001415889-22-002439
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hewes L. Becker
CENTRAL INDEX KEY: 0001840110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 22711563
MAIL ADDRESS:
STREET 1: C/O BLUEPRINT MEDICINES
STREET 2: CORPORATION
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4-03032022_050346.xml
X0306
4
2022-03-01
0001597264
Blueprint Medicines Corp
BPMC
0001840110
Hewes L. Becker
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
false
true
false
false
CHIEF MEDICAL OFFICER
Common Stock
2022-03-01
4
A
0
8750
0
A
34937
D
Stock Option (Right to Buy)
61.31
2022-03-01
4
A
0
17500
0
A
2032-03-01
Common Stock
17500
17500
D
The reported transaction involved the Reporting Person's receipt of grant of 8,750 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
This option vests with respect to 1/48th of the shares underlying the option on April 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Ariel Hurley, Attorney-in-Fact
2022-03-03